Related Experiment Video

Updated: May 10, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
14:47

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry

Published on: May 17, 2016

Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the

R Taulli1, V Foglizzo1, D Morena1

  • 11] Department of Oncology, University of Turin School of Medicine, Turin, Italy [2] CERMS, Center for Experimental Research and Medical Studies, Turin, Italy.

Oncogene
|June 4, 2013
PubMed

Insights

Re-expressing miR-206 in rhabdomyosarcoma (RMS) blocks tumor growth. This study identifies BAF53a as a direct target of miR-206, showing its silencing inhibits RMS growth and promotes differentiation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Rhabdomyosarcoma (RMS) is a pediatric soft tissue sarcoma with a partially differentiated myogenic phenotype.
  • miR-206, a muscle-specific microRNA, is downregulated in RMS, and its re-expression can inhibit tumor growth and restore differentiation.
  • The SWI/SNF chromatin remodeling complex subunit BAF53a is downregulated in miR-206-expressing RMS cells.

Purpose of the Study:

  • To investigate the role of BAF53a in RMS pathogenesis and its relationship with miR-206.
  • To determine if BAF53a is a direct target of miR-206.
  • To evaluate BAF53a as a potential therapeutic target for RMS.

Main Methods:

  • Quantitative real-time PCR to measure BAF53a transcript levels in RMS tumors and normal muscle.
  • Bioinformatic analysis and luciferase reporter assays to confirm BAF53a as a direct miR-206 target.
  • In vitro studies involving sustained BAF53a expression or silencing in myogenic cells and RMS cell lines.
  • In vivo studies assessing the effect of BAF53a silencing on RMS tumor growth in mouse models.

Main Results:

  • BAF53a transcript levels are significantly higher in primary RMS tumors compared to normal muscle.
  • BAF53a is a direct transcriptional target of miR-206.
  • Sustained BAF53a expression inhibits myogenic differentiation, while BAF53a silencing in RMS cells enhances myogenic markers, reduces proliferation, and inhibits anchorage-independent growth.
  • BAF53a silencing significantly impairs the growth of both embryonal RMS and alveolar RMS tumors, inducing differentiation.

Conclusions:

  • The failure to downregulate BAF53a may contribute to the development of RMS.
  • BAF53a plays a crucial role in maintaining the undifferentiated, proliferative state of RMS cells.
  • BAF53a represents a promising novel therapeutic target for rhabdomyosarcoma treatment.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...